Showing results (1-10 of 349) with videos related to
Sort By:
Pageof 35
Thrombosis and Haemostasis|March 1, 1996
DDAVP reduces bleeding during continued hirudin administration in the rabbitC M Bove, B Casey, V J MarderClinical Cardiology|April 1, 1990
Thrombolytic agents: balancing cost, efficacy, and side effectsV J MarderAnnals of Internal Medicine|May 1, 1979
The use of thrombolytic agents: choice of patient, drug administration, laboratory monitoringV J MarderCirculation|August 1, 1983
Pharmacology of thrombolytic agents. Implications for therapy of coronary artery thrombosisV J MarderThe American Journal of Cardiology|July 5, 1989
Comparison of thrombolytic agents: selected hematologic, vascular and clinical eventsV J MarderThrombosis and Haemostasis|July 1, 1995
Thrombolytic therapy: overview of results in major vascular occlusionsV J MarderJournal of Thrombosis and Haemostasis : JTH|July 26, 2011
Historical perspective and future direction of thrombolysis research: the re-discovery of plasminV J MarderAmerican Journal of Hospital Pharmacy|September 1, 1990
Bleeding complications of thrombolytic treatmentV J MarderThe American Journal of Medicine|August 24, 1987
Relevance of changes in blood fibrinolytic and coagulation parameters during thrombolytic therapyV J MarderAnnals of Internal Medicine|March 1, 1991
Streptokinase and recombinant tissue plasminogen activator (rt-PA) are equally effective in treating acute myocardial infarctionS Sherry, V J MarderPageof 35